Skip to main content
. 2019 Jan 30;19(4):2581–2590. doi: 10.3892/mmr.2019.9908

Figure 1.

Figure 1.

RP increases the cell viability of MI/R-induced cardiomyocytes. (A) CCK-8 assay was performed on the cell viability of cardiomyocytes treated with different concentrations of RP. (B) CCK-8 assay was conducted to test the cell viability of cardiomyocytes treated with MI/R, 20 µM RP+MI/R, 40 µM RP+MI/R and 80 µM RP+MI/R, respectively. *P<0.05 vs. Control. RP, rhynchophylline; MI/R, myocardial ischemia-reperfusion; CCK-8, Cell Counting Kit-8.